231 related articles for article (PubMed ID: 34079956)
1. The proliferative history shapes the DNA methylome of B-cell tumors and predicts clinical outcome.
Duran-Ferrer M; Clot G; Nadeu F; Beekman R; Baumann T; Nordlund J; Marincevic-Zuniga Y; Lönnerholm G; Rivas-Delgado A; Martín S; Ordoñez R; Castellano G; Kulis M; Queirós AC; Lee ST; Wiemels J; Royo R; Puiggrós M; Lu J; Giné E; Beà S; Jares P; Agirre X; Prosper F; López-Otín C; Puente XS; Oakes CC; Zenz T; Delgado J; López-Guillermo A; Campo E; Martín-Subero JI
Nat Cancer; 2020 Nov; 1(11):1066-1081. PubMed ID: 34079956
[TBL] [Abstract][Full Text] [Related]
2. An integrated genomics analysis of epigenetic subtypes in human breast tumors links DNA methylation patterns to chromatin states in normal mammary cells.
Holm K; Staaf J; Lauss M; Aine M; Lindgren D; Bendahl PO; Vallon-Christersson J; Barkardottir RB; Höglund M; Borg Å; Jönsson G; Ringnér M
Breast Cancer Res; 2016 Feb; 18(1):27. PubMed ID: 26923702
[TBL] [Abstract][Full Text] [Related]
3. Decoding the DNA Methylome of Mantle Cell Lymphoma in the Light of the Entire B Cell Lineage.
Queirós AC; Beekman R; Vilarrasa-Blasi R; Duran-Ferrer M; Clot G; Merkel A; Raineri E; Russiñol N; Castellano G; Beà S; Navarro A; Kulis M; Verdaguer-Dot N; Jares P; Enjuanes A; Calasanz MJ; Bergmann A; Vater I; Salaverría I; van de Werken HJG; Wilson WH; Datta A; Flicek P; Royo R; Martens J; Giné E; Lopez-Guillermo A; Stunnenberg HG; Klapper W; Pott C; Heath S; Gut IG; Siebert R; Campo E; Martín-Subero JI
Cancer Cell; 2016 Nov; 30(5):806-821. PubMed ID: 27846393
[TBL] [Abstract][Full Text] [Related]
4. Epigenomic Characterization of Lymphoid Neoplasms.
Duran-Ferrer M; Martín-Subero JI
Annu Rev Pathol; 2024 Jan; 19():371-396. PubMed ID: 37832942
[TBL] [Abstract][Full Text] [Related]
5. DNA methylation and cancer.
Kulis M; Esteller M
Adv Genet; 2010; 70():27-56. PubMed ID: 20920744
[TBL] [Abstract][Full Text] [Related]
6. An integrated epigenomic-transcriptomic landscape of lung cancer reveals novel methylation driver genes of diagnostic and therapeutic relevance.
Sun X; Yi J; Yang J; Han Y; Qian X; Liu Y; Li J; Lu B; Zhang J; Pan X; Liu Y; Liang M; Chen E; Liu P; Lu Y
Theranostics; 2021; 11(11):5346-5364. PubMed ID: 33859751
[No Abstract] [Full Text] [Related]
7. DNA hypomethylation in cancer cells.
Ehrlich M
Epigenomics; 2009 Dec; 1(2):239-59. PubMed ID: 20495664
[TBL] [Abstract][Full Text] [Related]
8. Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia.
Kulis M; Heath S; Bibikova M; Queirós AC; Navarro A; Clot G; Martínez-Trillos A; Castellano G; Brun-Heath I; Pinyol M; Barberán-Soler S; Papasaikas P; Jares P; Beà S; Rico D; Ecker S; Rubio M; Royo R; Ho V; Klotzle B; Hernández L; Conde L; López-Guerra M; Colomer D; Villamor N; Aymerich M; Rozman M; Bayes M; Gut M; Gelpí JL; Orozco M; Fan JB; Quesada V; Puente XS; Pisano DG; Valencia A; López-Guillermo A; Gut I; López-Otín C; Campo E; Martín-Subero JI
Nat Genet; 2012 Nov; 44(11):1236-42. PubMed ID: 23064414
[TBL] [Abstract][Full Text] [Related]
9. Epigenome-wide analysis of common warts reveals aberrant promoter methylation.
Al-Eitan LN; Alghamdi MA; Tarkhan AH; Al-Qarqaz FA
Int J Med Sci; 2020; 17(2):191-206. PubMed ID: 32038103
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic screen identifies genotype-specific promoter DNA methylation and oncogenic potential of CHRNB4.
Scherf DB; Sarkisyan N; Jacobsson H; Claus R; Bermejo JL; Peil B; Gu L; Muley T; Meister M; Dienemann H; Plass C; Risch A
Oncogene; 2013 Jul; 32(28):3329-38. PubMed ID: 22945651
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide DNA methylation analysis reveals molecular subtypes of pancreatic cancer.
Mishra NK; Guda C
Oncotarget; 2017 Apr; 8(17):28990-29012. PubMed ID: 28423671
[TBL] [Abstract][Full Text] [Related]
12. Decoding the regulatory landscape of medulloblastoma using DNA methylation sequencing.
Hovestadt V; Jones DT; Picelli S; Wang W; Kool M; Northcott PA; Sultan M; Stachurski K; Ryzhova M; Warnatz HJ; Ralser M; Brun S; Bunt J; Jäger N; Kleinheinz K; Erkek S; Weber UD; Bartholomae CC; von Kalle C; Lawerenz C; Eils J; Koster J; Versteeg R; Milde T; Witt O; Schmidt S; Wolf S; Pietsch T; Rutkowski S; Scheurlen W; Taylor MD; Brors B; Felsberg J; Reifenberger G; Borkhardt A; Lehrach H; Wechsler-Reya RJ; Eils R; Yaspo ML; Landgraf P; Korshunov A; Zapatka M; Radlwimmer B; Pfister SM; Lichter P
Nature; 2014 Jun; 510(7506):537-41. PubMed ID: 24847876
[TBL] [Abstract][Full Text] [Related]
13. Epigenome-wide DNA methylation analysis of small cell lung cancer cell lines suggests potential chemotherapy targets.
Krushkal J; Silvers T; Reinhold WC; Sonkin D; Vural S; Connelly J; Varma S; Meltzer PS; Kunkel M; Rapisarda A; Evans D; Pommier Y; Teicher BA
Clin Epigenetics; 2020 Jun; 12(1):93. PubMed ID: 32586373
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic and genetic burden measures are associated with tumor characteristics in invasive breast carcinoma.
O'Sullivan DE; Johnson KC; Skinner L; Koestler DC; Christensen BC
Epigenetics; 2016 May; 11(5):344-53. PubMed ID: 27070496
[TBL] [Abstract][Full Text] [Related]
15. Intra-individual methylomics detects the impact of early-life adversity.
Jiang S; Kamei N; Bolton JL; Ma X; Stern HS; Baram TZ; Mortazavi A
Life Sci Alliance; 2019 Apr; 2(2):. PubMed ID: 30936186
[TBL] [Abstract][Full Text] [Related]
16. DNA methylation aberrancies as a guide for surveillance and treatment of human cancers.
Liang G; Weisenberger DJ
Epigenetics; 2017 Jun; 12(6):416-432. PubMed ID: 28358281
[TBL] [Abstract][Full Text] [Related]
17. Charting the dynamic epigenome during B-cell development.
Martin-Subero JI; Oakes CC
Semin Cancer Biol; 2018 Aug; 51():139-148. PubMed ID: 28851627
[TBL] [Abstract][Full Text] [Related]
18. Correlation of an epigenetic mitotic clock with cancer risk.
Yang Z; Wong A; Kuh D; Paul DS; Rakyan VK; Leslie RD; Zheng SC; Widschwendter M; Beck S; Teschendorff AE
Genome Biol; 2016 Oct; 17(1):205. PubMed ID: 27716309
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic regulation of DNA repair genes and implications for tumor therapy.
Christmann M; Kaina B
Mutat Res Rev Mutat Res; 2019; 780():15-28. PubMed ID: 31395346
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide methylation profiling of ovarian cancer patient-derived xenografts treated with the demethylating agent decitabine identifies novel epigenetically regulated genes and pathways.
Tomar T; de Jong S; Alkema NG; Hoekman RL; Meersma GJ; Klip HG; van der Zee AG; Wisman GB
Genome Med; 2016 Oct; 8(1):107. PubMed ID: 27765068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
